LON:HNT - Huntsworth Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0
+0.30 (1.20%)

This chart shows the closing price for HNT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Huntsworth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HNT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HNT

Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for Huntsworth in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.

This chart shows the closing price for HNT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Huntsworth. This rating has held steady since February 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/5/2020
  • 1 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/3/2020
  • 1 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/18/2020Liberum CapitalReiterated RatingHold
3/5/2020Berenberg BankDowngradeHoldGBX 125 ➝ GBX 108
3/3/2020Liberum CapitalDowngradeHoldGBX 110 ➝ GBX 108
3/3/2020Peel HuntReiterated RatingAdd
2/24/2020Peel HuntReiterated RatingAdd
2/7/2020Royal Bank of CanadaReiterated RatingTop pick
1/20/2020Peel HuntReiterated RatingAdd
1/13/2020Liberum CapitalLower Price TargetBuyGBX 120 ➝ GBX 110
12/17/2019Peel HuntDowngradeAddGBX 135 ➝ GBX 120
12/17/2019Liberum CapitalReiterated RatingBuy
11/19/2019Peel HuntReiterated RatingBuy
11/15/2019Liberum CapitalReiterated RatingBuy
10/10/2019Berenberg BankReiterated RatingBuy
10/8/2019Peel HuntReiterated RatingBuy
10/1/2019Peel HuntReiterated RatingBuyGBX 135
10/1/2019Peel HuntReiterated RatingBuyGBX 135
9/30/2019Liberum CapitalInitiated CoverageBuyGBX 120
9/4/2019Peel HuntReiterated RatingBuy
7/22/2019Peel HuntReiterated RatingBuy
7/15/2019Peel HuntReiterated RatingBuy
7/3/2019Peel HuntReiterated RatingBuyGBX 135
7/3/2019Peel HuntReiterated RatingBuyGBX 135
6/3/2019Peel HuntBoost Price TargetBuyGBX 130 ➝ GBX 135
5/23/2019Berenberg BankBoost Price TargetBuyGBX 120 ➝ GBX 125
5/21/2019Peel HuntReiterated RatingBuy
5/21/2019Numis SecuritiesReiterated RatingBuy
5/9/2019Numis SecuritiesReiterated RatingBuyGBX 165
5/9/2019Peel HuntReiterated RatingBuy
5/2/2019Berenberg BankLower Price TargetBuyGBX 140 ➝ GBX 120
5/2/2019Peel HuntReiterated RatingBuy
4/1/2019Peel HuntReiterated RatingBuy
3/13/2019Peel HuntReiterated RatingBuy
3/5/2019Peel HuntReiterated RatingBuy
2/13/2019Peel HuntReiterated RatingBuy
1/24/2019Peel HuntUpgradeBuyGBX 140 ➝ GBX 130
12/12/2018Peel HuntReiterated RatingAdd
12/5/2018Peel HuntReiterated RatingAdd
11/27/2018Berenberg BankLower Price TargetBuyGBX 150 ➝ GBX 140
11/2/2018Peel HuntReiterated RatingAdd
10/8/2018Peel HuntReiterated RatingAdd
9/28/2018Numis SecuritiesReiterated RatingBuy
9/28/2018Peel HuntReiterated RatingAdd
9/5/2018Peel HuntReiterated RatingAdd
8/15/2018Berenberg BankBoost Price TargetBuyGBX 135 ➝ GBX 150
8/2/2018Peel HuntReiterated RatingAdd
7/24/2018Numis SecuritiesReiterated RatingBuy
7/24/2018Peel HuntReiterated RatingAdd
7/18/2018Peel HuntDowngradeAddGBX 115 ➝ GBX 140
7/17/2018Peel HuntReiterated RatingBuy
7/17/2018Numis SecuritiesBoost Price TargetBuyGBX 109 ➝ GBX 165
7/3/2018Peel HuntReiterated RatingBuy
6/6/2018Berenberg BankInitiated CoverageBuyGBX 135
6/4/2018Peel HuntReiterated RatingBuy
5/24/2018Peel HuntReiterated RatingBuy
5/4/2018Peel HuntReiterated RatingBuyGBX 115
4/4/2018Peel HuntReiterated RatingBuy
3/16/2018Peel HuntBoost Price TargetBuyGBX 95 ➝ GBX 115
3/6/2018Numis SecuritiesBoost Price TargetBuyGBX 102 ➝ GBX 109
3/5/2018Peel HuntReiterated RatingBuyGBX 95
2/28/2018Numis SecuritiesReiterated RatingBuyGBX 102
1/17/2018Peel HuntReiterated RatingBuyGBX 95
12/14/2017Peel HuntBoost Price TargetBuyGBX 80 ➝ GBX 95
7/26/2017Numis SecuritiesBoost Price TargetBuyGBX 77 ➝ GBX 85
7/26/2017Peel HuntBoost Price TargetBuyGBX 70 ➝ GBX 80
7/17/2017Peel HuntReiterated RatingBuyGBX 70
7/3/2017Peel HuntBoost Price TargetBuyGBX 65 ➝ GBX 70
7/3/2017Numis SecuritiesBoost Price TargetBuyGBX 71 ➝ GBX 77
6/9/2017Peel HuntReiterated RatingBuyGBX 65
5/31/2017Peel HuntReiterated RatingBuyGBX 65
5/25/2017Numis SecuritiesReiterated RatingBuyGBX 71
5/25/2017Peel HuntReiterated RatingBuyGBX 65
4/3/2017Peel HuntReiterated RatingBuyGBX 65
3/21/2017Numis SecuritiesBoost Price TargetBuyGBX 60 ➝ GBX 63
3/14/2017Numis SecuritiesBoost Price TargetBuyGBX 57 ➝ GBX 60
2/16/2017Numis SecuritiesReiterated RatingBuyGBX 60
1/5/2017InvestecReiterated RatingBuyGBX 50
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Huntsworth logo
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams. This division serves pharmaceutical and biotechnology clients. The Marketing division markets prescription drugs to consumers and healthcare professionals; and provides healthcare public relations agency and payer marketing services. This segment serves biotech and pharma, OTC, wellness, and lifestyle brands. The Immersive division creates and delivers live experiences, and scientific and interactive contents; creates and produces various films, including short and internal engagement films, documentaries, and action demonstrations; develops immersive experiences for employees training and explaining complex science; and designs strategic and creative programs to engage internal audiences. This division primarily serves healthcare industry. The Communications division provides public relations and affairs, and investor relations solutions; and communication consulting services primarily for cross-border financial transactions and multinationals to broaden their global footprint, as well as develops and manages campaigns, runs press offices, and steers brands and businesses through engagement with media, consumers, customer stakeholders, and internal audiences. The company was formerly known as Holmes & Marchant Group plc and changed its name to Huntsworth plc in July 1999. Huntsworth plc was incorporated in 1983 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 107.50
Low: 107.50
High: 107.50

52 Week Range

Now: N/A

Volume

505,026 shs

Average Volume

5,456,616 shs

Market Capitalization

£399.60 million

P/E Ratio

19.91

Dividend Yield

2.42%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Huntsworth?

The following Wall Street sell-side analysts have issued stock ratings on Huntsworth in the last twelve months:
View the latest analyst ratings for HNT.

What is the current price target for Huntsworth?

0 Wall Street analysts have set twelve-month price targets for Huntsworth in the last year. has the lowest price target set, forecasting a price of £100,000 for Huntsworth in the next year.
View the latest price targets for HNT.

What is the current consensus analyst rating for Huntsworth?

Huntsworth currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HNT.

How do I contact Huntsworth's investor relations team?

Huntsworth's physical mailing address is 8th Fl Holborn Gate, 26 Southampton Buildings, LONDON, WC2A 1AN, United Kingdom. The company's listed phone number is +44-20-72248778. The official website for Huntsworth is www.huntsworth.com.